A study led by Johns Hopkins describes a method for automating slow, inaccurate manual chart review when searching for signs of misdiagnosis.
The company estimates that the quality control issue resulted in between two and 15 patients getting a false negative result.
DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.
Regulators have proposed banning Theranos CEO from owning or operating any lab for two years, the Wall Street Journal reports.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.